-
Derivation of Doxorubicin Mutational Signatures in Cancer
Study
phs004740
-
Natural History Study of Non-A, Non-B Post-Transfusion Hepatitis (NANB-TAH_BioLINCC)
Study
phs004538
-
Immune Contexture of Colorectal Adenomas and Serrated Polyps
Study
phs004106
-
Long-Read Sequencing of Ovarian Cancer Organoids
Study
phs004795
-
A091401 Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Patients With Metastatic or Unresectable Sarcoma
Study
phs003785
-
Childhood Cancer Data Initiative (CCDI): A Cohort of Hispanic Children with Acute Lymphoblastic Leukemia; Bloom Syndrome in a Mexican American Family with Rhabdomyosarcoma
Study
phs002823
-
Therapeutic Hypothermia After Pediatric Cardiac Arrest (Out of Hospital) (THAPCA-OH-BioLINCC)
Study
phs004646
-
Blood and Marrow Clinical Trials Network - A Multi-center Phase II Trial Randomizing Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN-1203-BioLINCC)
Study
phs004709
-
The Critical Role of the Host Endogenous Immune Compartment After Intracerebroventricular CAR T-Cell Therapy in Recurrent GBM
Study
phs004571
-
Multiregion Biopsies and Corresponding Neurosphere Cultures Reveal Spatial Divergence in Glioblastoma
Study
phs004410
-
NCTN: A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma (CALGB-90601)
Study
phs004243
-
NCTN: A Randomized Phase III Study of Ibrutinib (PCI-32765)-Based Therapy vs Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL) (E1912)
Study
phs004233
-
Correlative Studies in Protocol GU16-287, which Studied Gemcitabine + (Carboplatin or Oxaliplatin) + Nivolumab in Metastatic Urothelial Cancer, which Included Collaboration with CIMAC-CIDC (Cohort 1 of 3)
Study
phs004060
-
Blood and Marrow Transplant Clinical Trials Network A Trial of Single Autologous Transplant With or Without Consolidation Therapy Versus Tandem Autologous Transplant With Lenalidomide Maintenance for Patients With Multiple Myeloma (BMT CTN-0702-BioLINCC)
Study
phs004692
-
Fusion Transcription Factor Dosage Controls Cell State in Rhabdomyosarcoma
Study
phs004381
-
Childhood Cancer Data Initiative (CCDI): Whole Genome Landscapes of Patient Derived Osteosarcoma Xenograft Models
Study
phs004232
-
Effector CD4 T Cells Convert Transient Responses to KRAS-Targeted Therapy into Long-Term Durable Remissions in Pancreatic Cancer
Study
phs004509
-
Blood and Marrow Transplant Clinical Trials Network - A Phase II Multicenter Trial of Single Autologous Hematopoietic Cell Transplant Followed by Lenalidomide Maintenance for Multiple Myeloma with or without Vaccination with Dendritic Cell/Myeloma Fusions (BMT CTN-1401-BioLINCC)
Study
phs004718
-
The Electronic Medical Records and GEnomics Network Genomic Risk Assessment (eMERGE IV)
Study
phs003905
-
IMPACT Study: Single-Cell RNA-Seq before and after Vaccination for SARS-CoV-2 in Patients with Multiple Myeloma and its Precursor Conditions
Study
phs004542
-
NCTN: A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) With or Without Cetuximab (C225) After Curative Resection for Patients With Stage III Colon Cancer (N0147)
Study
phs004241
-
Blood and Marrow Clinical Trials Network - A Multi-Center, Phase III, Randomized Trial of RIC, and Transplantation of (dUCB) Versus HLA-Haplo Related Bone Marrow for Patients with Hematologic Malignancies (BMT CTN-1101-BioLINCC)
Study
phs004698
-
Feasibility of Circulating 5-Hydroxymethylcytosine Profiling in Osteosarcoma
Study
phs003842
-
Cancer Associated Fibroblasts Drive Epithelial to Mesenchymal Transition and Classical to Basal Change in Pancreatic Cancer Cells with Loss of IL-8 Expression
Study
phs004499
-
Childhood Cancer Data Initiative (CCDI): CCDI Pediatric In Vivo Testing Program - Orthotopic CNS Tumors
Study
phs003162
-
Impact of HLA Aberrations on Tumor Neoepitope Presentation
Study
phs004529
-
Exome and Multi-Site Bulk and scRNA-seq Profiling of Pleural Mesothelioma
Study
phs004285
-
HRDetect in Tubo-Ovarian Carcinoma: Stratification and Therapeutic Implications
Study
phs004452
-
Functional Genomics and Tumor Microenvironment Analysis Reveal Prognostic Biological Subtypes in Mantle Cell Lymphoma
Study
phs003849
-
Cellular and Molecular Profiling of Epithelial Ovarian Cancers and Associated Normal Tissues
Study
phs004702
-
Blood and Marrow Clinical Trials Network Trial of Non-Myeloablative Conditioning and Transplantation of Umbilical Cord Blood For Hematologic Malignancies (BMT CTN-0604-BioLINCC)
Study
phs004890
-
BTC GBM TeamLab Trial 1: Longitudinal Tissue Profiling of Recurrent Malignant Glioma During Repeat Dosing of Oncolytic Viral Immunotherapy (NCT03152318)
Study
phs004189
-
scRNAseq of Human Urothelial Carcinoma
Study
phs003405
-
5-Hydroxymethylcytosine Profiling of Cell-Free DNA Disease Detection in High-Risk Relapsed or Refractory Neuroblastoma
Study
phs004894
-
Dissecting the Role of the Microenvironment in Follicular Lymphoma Transformation
Study
phs004175
-
Correlative Studies in Protocol E4412, which Studied Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma, in Collaboration with CIMAC-CIDC
Study
phs003450
-
Integrating Contemporary Biospecimens and Immunomethylomics into the study of the Glioma Genetics and Immunity - CIDR
Study
phs003990
-
Genome-Wide Association Study for Glucocorticoid-Induced Ocular Hypertension
Study
phs004037
-
MP2PRT: Discovering Biomarkers of Outcome: EBV DNA Quantification and the Relationship of EBV and LINE1 Retrotransposon Expression in Pediatric Patients With Nasopharyngeal Carcinoma (NPC) Enrolled on ARAR0331
Study
phs003092
-
Clonal Heterogeneity in Human Pancreatic Ductal Adenocarcinoma and Its Impact on Tumor Progression
Study
phs004079
-
Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies
Study
phs004471
-
Phase II Study of Single-Agent Daratumumab in Patients with High-Risk Monoclonal Gammopathy of Undetermined Significance (MGUS) and Low-Risk Smoldering Multiple Myeloma (SMM)
Study
phs004127
-
NCTN: Phase III Randomized Study of Sorafenib Plus Doxorubicin versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC) (CALGB-80802)
Study
phs004239
-
SMARCB1 Missense Mutants Destabilize SWI/SNF Complex Stability and Remodeling Activity
Study
phs003896
-
Kids First: Childhood Cancer Data Initiative (CCDI) - Discovering the Timing and Origins of Bone and Soft Tissue Cancers
Study
phs002827
-
NCTN: A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children with Newly Diagnosed High Risk Hodgkin Lymphoma (AHOD0831)
Study
phs004161
-
Out-of-Frame CBX3::ALK Fusion Drives ALK Activation and Therapy Response
Study
phs004503
-
NCTN: A Randomized Phase III Trial of CC-5013 (Lenalidomide) and Low Dose Dexamethasone (LLD) versus Bortezomib, Lenalidomide and Low Dose Dexamethasone (BLLD) for Induction, in Patients with Previously Untreated Multiple Myeloma (S0777)
Study
phs004247
-
Molecular Markers of Risk of Subsequent Invasive Breast Cancer in Women with Ductal Carcinoma in Situ
Study
phs004440
-
Women's Health Initiative (WHI) - Life and Longevity After Cancer (LILAC) (WHI-LILAC-BioLINCC)
Study
phs004174